Literature DB >> 3019192

Investigation of possible vaccine-induced epizootics of infectious bovine rhinotracheitis, using restriction endonuclease analysis of viral DNA.

C A Whetstone, J G Wheeler, D E Reed.   

Abstract

Viral DNA was extracted from each of 14 modified-live (ML) bovine herpesvirus 1 vaccines, representing all of the ML infectious bovine rhinotracheitis virus (IBRV) vaccines licensed by the US Department of Agriculture for use in cattle. Restriction endonucleases Pst I and Bgl II were used to establish restriction enzyme patterns for the vaccinal viruses. Viral DNA from isolates obtained from 6 field samples of IBRV (1 from Colorado, 1 from West Virginia, 3 from Wisconsin, 1 from South Dakota) were digested with restriction endonucleases, and patterns were compared to evaluate the role of vaccinal virus in these field epizootics of infectious bovine rhinotracheitis. Animals from which field samples were obtained had been vaccinated with ML IBRV vaccine before the epizootic of infectious bovine rhinotracheitis occurred in the herds. In 2 of the 6 field samples, DNA restriction endonuclease analyses patterns from the isolates were indistinguishable from the pattern for the vaccinal viruses used. In the remaining 4 field samples, DNA restriction endonuclease analyses patterns of the IBRV from isolates were different from those of the vaccinal viruses.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019192

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  12 in total

1.  Bovine herpesvirus 1 isolates contain variable copy numbers of GC-rich tandem repeats in the gI non-coding regions of their genomes.

Authors:  S A Nadin-Davis; C Lutze-Wallace; X Zhong
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

Review 2.  BHV-1: new molecular approaches to control a common and widespread infection.

Authors:  L Turin; S Russo; G Poli
Journal:  Mol Med       Date:  1999-05       Impact factor: 6.354

3.  Bovine herpesvirus 1 VP22 enhances the efficacy of a DNA vaccine in cattle.

Authors:  Chunfu Zheng; Lorne A Babiuk; Sylvia van Drunen Littel-van den Hurk
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  Anti-idiotypic antibodies induce neutralizing antibodies to bovine herpesvirus 1.

Authors:  S Srikumaran; D V Onisk; M V Borca; C Nataraj; T J Zamb
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

5.  Two different strains of an alphaherpesvirus can establish latency in the same tissue of the host animal: evidence from bovine herpesvirus 1.

Authors:  C A Whetstone; J M Miller
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

6.  Expression of bovine herpesvirus 1 glycoprotein gIV by recombinant baculovirus and analysis of its immunogenic properties.

Authors:  S van Drunen Littel-van den Hurk; M D Parker; D R Fitzpatrick; T J Zamb; J V van den Hurk; M Campos; R Harland; L A Babiuk
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

7.  Transcriptional analysis of the bovine herpesvirus 1 Cooper isolate. Temporal analysis and characterization of immediate-early, early, and late RNA.

Authors:  B S Seal; J M Irving; C A Whetstone
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

8.  Reintroduction of bovine herpes virus type 1 into Danish cattle herds during the period 1991-1995: a review of the investigations in the infected herds.

Authors:  B Nylin; K G Madsen; L Rønsholt
Journal:  Acta Vet Scand       Date:  1998       Impact factor: 1.695

9.  Fatal, generalized bovine herpesvirus type-1 infection associated with a modified-live infectious bovine rhinotracheitis parainfluenza-3 vaccine administered to neonatal calves.

Authors:  L A Bryan; R A Fenton; V Misra; D M Haines
Journal:  Can Vet J       Date:  1994-04       Impact factor: 1.008

10.  The effect of subunit or modified live bovine herpesvirus-1 vaccines on the efficacy of a recombinant Pasteurella haemolytica vaccine for the prevention of respiratory disease in feedlot calves.

Authors:  R J Harland; A A Potter; S van Drunen-Littel-van den Hurk; J Van Donkersgoed; M D Parker; T J Zamb; E D Janzen
Journal:  Can Vet J       Date:  1992-11       Impact factor: 1.008

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.